China & Manufacturing Patent Grants

We’ve achieved some exciting IP milestones for Calla Lily Clinical Care; making strong progress in building a robust IP strategy and IP portfolio to protect and advance our innovations in womenโ€™s health.

๐Ÿ’ฅ China Patent Grant for our Drug Delivery Device ๐ŸŒ
At long last, one of our vaginal drug delivery applications in China has been granted (ZL202080032097.8) โ€” a significant milestone in our global IP strategy. With declining birthrates in China, Japan, Korea and Singapore ๐Ÿ“‰ , the need for technologies that support IVF and miscarriage prevention has never been more urgent. We now have granted patents in *all* of these key markets, further solidifying our presence in Asia.

๐Ÿ’ฅ UK Patent Grant for our Manufacturing Innovation ๐ŸŒ
During the last year we have also secured a UK patent (GB2590903) covering our proprietary joining technologyโ€” a critical innovation in how our device integrates multiple component materials. I still recall the in-depth discussions with our technical team and IP advisors debating which novel aspects of our manufacturing should be patented and which to keep as trade secrets โ€” an illustration that strategic IP decisions are never straightforward!

Developing a strong, defensible, and valuable IP portfolio is a complex, resource-intensive process.ย Congratulations to our team and external IP advisorsโ€” led by our CFO and head of IP, Stuart Princeโ€”for driving these efforts forward! ๐Ÿ’ช

๋‹น์‚ฌ๋Š” ์›น์‚ฌ์ดํŠธ ๊ฒฝํ—˜์„ ํ–ฅ์ƒ์‹œํ‚ค๊ธฐ ์œ„ํ•ด ์ฟ ํ‚ค๋ฅผ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค. ๋‹น์‚ฌ๋Š” ์›น์‚ฌ์ดํŠธ ๊ธฐ๋Šฅ์ด ์˜ฌ๋ฐ”๋กœ ๊ตฌํ˜„๋˜๋„๋ก ๋งŒ๋“ค๊ณ  ๋ณด์•ˆ์„ ์œ ์ง€ํ•˜๊ธฐ ์œ„ํ•ด์„œ ํ•„์š”ํ•œ ์ฟ ํ‚ค๋ฅผ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์ฟ ํ‚ค๋ฅผ ํ•ญ์ƒ ์‚ฌ์šฉํ•˜๋„๋ก ์„ค์ •ํ•ด์•ผ ํ•ฉ๋‹ˆ๋‹ค. โ€œ์ฟ ํ‚ค ์ˆ˜๋ฝโ€์„ ํด๋ฆญํ•˜๋ฉด ์›น์‚ฌ์ดํŠธ ํƒ์ƒ‰์„ ๊ฐœ์„ ํ•˜๊ณ  ์›น์‚ฌ์ดํŠธ ์ด์šฉ์„ ๋ถ„์„ํ•˜๊ณ  ๋งˆ์ผ€ํŒ… ๋…ธ๋ ฅ์„ ์ง€์›ํ•  ์ˆ˜ ์žˆ๋„๋ก ๊ธฐ๊ธฐ์— ์ฟ ํ‚ค๋ฅผ ์ €์žฅํ•˜๋Š” ๊ฒƒ์— ๋™์˜ํ•˜๊ฒŒ ๋ฉ๋‹ˆ๋‹ค. ์ž์„ธํ•œ ๋‚ด์šฉ์€ ๊ฐœ์ธ ์ •๋ณด ๋ณด์•ˆ ์ •์ฑ…์„ ์ฐธ์กฐํ•˜์‹ญ์‹œ์˜ค.